Hanyong Chen

2.8k citations

76 papers · 2.1k indexed · h-index 29

Impact in

Pharmacology top 2%
- Pharmacological Effects of Natural Compounds
Biochemistry top 5%
- Phytochemicals and Antioxidant Activities

Papers in

Co-authors: Zigang Dong Ann M. Bode Kangdong Liu Ki Won Lee Do Young Lim Mee‐Hyun Lee Ke Yao Sungyoung Lee
Journals: Cancer Research (10 papers)Cancer Prevention Research (10 papers)Molecular Carcinogenesis (7 papers)Oncotarget (4 papers)Oncogene (4 papers)
Partner nations: United States China South Korea

In The Last Decade

Hanyong Chen

74 papers receiving 2.1k citations

Peers

Countries citing papers authored by Hanyong Chen

Since Specialization

Citations

This map shows the geographic impact of Hanyong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanyong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanyong Chen more than expected).

Fields of papers citing papers by Hanyong Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanyong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanyong Chen. The network helps show where Hanyong Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Hanyong Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hanyong Chen Line = papers co-authored together Hanyong Chen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Targeting TAOK1 with resveratrol inhibits esophageal squamous cell carcinoma growth in vitro and in vivo Molecular Carcinogenesis ·Mengqiu Song, Elena Kolcheva, K. Sunner, Yunqing Zhang, Shihui Liu, Kyle Vaughn Laster, Bu Young Choi, S. Vadlamudi, Tingxuan Gu, Hanyong Chen, Kangdong Liu, Mee‐Hyun Lee, Zigang Dong	2024	3
2	ARC Is a Critical Protector against Inflammatory Bowel Disease (IBD) and IBD-Associated Colorectal Tumorigenesis Cancer Research ·Qiushi Wang, Tianshun Zhang, Wang Jinsui, Do Young Lim, Keke Wang, Ruihua Bai, Ting Wang, Joohyun Ryu, Hanyong Chen, Ke Yao, Wei-Ya Ma, Lisa A. Boardman, Ann M. Bode, Zigang Dong	2020	5
3	GSK3β-Mediated Expression of CUG-Translated WT1 Is Critical for Tumor Progression Cancer Research ·ปาริชาต พุดน้อย, Kun Y. Lee, Ke Yao, Seung Ho Shin, Tianshun Zhang, Qiushi Wang, Souren Paul, Eunmiri Roh, Joohyun Ryu, Hanyong Chen, Faisal Aziz, Abhijit Chakraborty, Ann M. Bode, Zigang Dong	2020	7
4	Discovery of a novel dual-target inhibitor against RSK1 and MSK2 to suppress growth of human colon cancer Oncogene ·Guoguo Jin, 西村優子, Kangdong Liu, Ke Yao, Hanyong Chen, Chengjuan Zhang, H. B., Kanamata Reddy, Ljiljana A. Jelenković, Kyle Vaughn Laster, Zhiping Guo, Zigang Dong	2020	16
5	Scutellarin Suppresses Patient-Derived Xenograft Tumor Growth by Directly Targeting AKT in Esophageal Squamous Cell Carcinoma Cancer Prevention Research ·Feifei Liu, M Hafiani, Xiaomeng Xie, Yuanyuan Zhang, Kangdong Liu, Hanyong Chen, Ting Wang, Ann M. Bode, Zigang Dong, Dong Joon Kim	2019	11
6	3,3'-Diindolylmethane inhibits patient-derived xenograft colon tumor growth by targeting COX1/2 and ERK1/2 Cancer Letters ·Xueli Tian, Kangdong Liu, M Hafiani, M. Cem Altun, Zhi Li, Mee‐Hyun Lee, Hanyong Chen, Yan Li, Yuzhou Zhao, Fangfang Liu, Naomi Oi, Ann M. Bode, Zigang Dong, Dong Joon Kim	2019	36
7	The Ashitaba ( Angelica keiskei ) Chalcones 4-hydroxyderricin and Xanthoangelol Suppress Melanomagenesis By Targeting BRAF and PI3K Cancer Prevention Research ·Tianshun Zhang, Qiushi Wang, Leander Kauschke, Ge Gao, Keke Wang, Hanyong Chen, Ting Wang, Naomi Oi, Tatyana A. Zykova, Kanamata Reddy, Ke Yao, Weiya Ma, Wang Jinsui, Mee‐Hyun Lee, Moeez Rathore, Ann M. Bode, Hitoshi Ashida, Scott M. Lippman, Zigang Dong	2018	11
8	Targeting AKT with Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma In Vitro and Patient-Derived Xenografts In Vivo Molecular Cancer Therapeutics ·Mengqiu Song, Xuejiao Liu, Kangdong Liu, Ran Zhao, Hai Huang, Yuanyuan Shi, Man Zhang, Alan Hoffmeister, Hua Xie, Hanyong Chen, Yin Li, Yan Zheng, Qiong Wu, Fangfang Liu, En‐Min Li, Ann M. Bode, Zigang Dong, Mee‐Hyun Lee	2018	73
9	ADA-07 Suppresses Solar Ultraviolet–Induced Skin Carcinogenesis by Directly Inhibiting TOPK Molecular Cancer Therapeutics ·Ge Gao, Tianshun Zhang, Cavid Wilkinson, Kanamata Reddy, Hanyong Chen, Ke Yao, Keke Wang, Eunmiri Roh, Tatyana A. Zykova, Weiya Ma, Joohyun Ryu, Clara Curiel‐Lewandrowski, David S. Alberts, Sally E. Dickinson, Ann M. Bode, Ying Xing, Zigang Dong	2017	27
10	The Prolyl Isomerase Pin1 Is a Novel Target of 6,7,4′-Trihydroxyisoflavone for Suppressing Esophageal Cancer Growth Cancer Prevention Research ·Tae‐Gyu Lim, Sungyoung Lee, Masataka Yamawaki, Mee‐Hyun Lee, Hanyong Chen, Fangfang Liu, Kangdong Liu, Sung Keun Jung, Dong Joon Kim, Ann M. Bode, Ki Won Lee, Zigang Dong	2017	18
11	A Novel Cinnamon-Related Natural Product with Pim-1 Inhibitory Activity Inhibits Leukemia and Skin Cancer Cancer Research ·Jong‐Eun Kim, Joe Eun Son, Hyein Jeong, Dong Joon Kim, Sang Gwon Seo, Eunjung Lee, Zhongyuan Wu, Jong Rhan Kim, 寛小松, Hanyong Chen, Ann M. Bode, Ki Won Lee, Zigang Dong	2015	30
12	Curcumin Suppresses Proliferation of Colon Cancer Cells by Targeting CDK2 Cancer Prevention Research ·Tae‐Gyu Lim, Sungyoung Lee, Zunnan Huang, Do Young Lim, Hanyong Chen, Sung Keun Jung, Ann M. Bode, Ki Won Lee, Zigang Dong	2014	91
13	Caffeic Acid Directly Targets ERK1/2 to Attenuate Solar UV-Induced Skin Carcinogenesis Cancer Prevention Research ·Ge Yang, Yang Fu, Margarita Malakhova, Igor Kurinov, Feng Zhu, Ke Yao, Haitao Li, Hanyong Chen, Wěi Li, Do Young Lim, Yuqiao Sheng, Ann M. Bode, Ziming Dong, Zigang Dong	2014	47
14	Kaempferol Targets RSK2 and MSK1 to Suppress UV Radiation-Induced Skin Cancer Cancer Prevention Research ·Ke Yao, Hanyong Chen, Kangdong Liu, Alyssa Langfald, Ge Yang, Yi Zhang, Dong Hoon Yu, Myoung Ok Kim, Mee‐Hyun Lee, Haitao Li, Ki Beom Bae, Hong-Gyum Kim, Weiya Ma, Ann M. Bode, Ziming Dong, Zigang Dong	2014	58
15	Eupafolin suppresses prostate cancer by targeting phosphatidylinositol 3‐kinase‐mediated Akt signaling Molecular Carcinogenesis ·Kangdong Liu, Chanmi Park, Hanyong Chen, Joonsung Hwang, N. R. Thimmegowda, Eun Young Bae, Ki Won Lee, Yuhki NAGATA, Haidan Liu, Nak‐Kyun Soung, Cong Peng, Jae Hyuk Jang, Kyoon Eon Kim, Jong Seog Ahn, Ann M. Bode, Ziming Dong, Bo Yeon Kim, Zigang Dong	2014	30
16	Licochalcone A, a Natural Inhibitor of c-Jun N -Terminal Kinase 1 Cancer Prevention Research ·Ke Yao, Hanyong Chen, Mee‐Hyun Lee, Haitao Li, Weiya Ma, Cong Peng, Nu Ry Song, Ki Won Lee, Ann M. Bode, Ziming Dong, Zigang Dong	2013	36
17	Naproxen Induces Cell-Cycle Arrest and Apoptosis in Human Urinary Bladder Cancer Cell Lines and Chemically Induced Cancers by Targeting PI3K Cancer Prevention Research ·Mi-Sung Kim, Jong‐Eun Kim, Do Young Lim, Zunnan Huang, Hanyong Chen, Alyssa Langfald, Ronald A. Lubet, Clinton J. Grubbs, Zigang Dong, Ann M. Bode	2013	69
18	Esculetin Suppresses Proliferation of Human Colon Cancer Cells by Directly Targeting β-Catenin Cancer Prevention Research ·Sungyoung Lee, Tae‐Gyu Lim, Hanyong Chen, Sung Keun Jung, Hyo‐Jeong Lee, Mee‐Hyun Lee, Dong Joon Kim, Aram Shin, Ki Won Lee, Ann M. Bode, Young‐Joon Surh, Zigang Dong	2013	62
19	Select Dietary Phytochemicals Function as Inhibitors of COX-1 but Not COX-2 PLoS ONE ·Haitao Li, Feng Zhu, Yanwen Sun, Bing Li, Naomi Oi, Hanyong Chen, Ronald A. Lubet, Ann M. Bode, Zigang Dong	2013	4
20	Taxifolin Suppresses UV-Induced Skin Carcinogenesis by Targeting EGFR and PI3K Cancer Prevention Research ·Naomi Oi, Hanyong Chen, Myoung Ok Kim, Ronald A. Lubet, Ann M. Bode, Zigang Dong	2012	72

About Hanyong Chen

Hanyong Chen is a scholar working on Applied Microbiology and Biotechnology, Biochemistry, Oncology, Pathology and Forensic Medicine and Molecular Biology, having authored 76 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (10 papers), Melanoma and MAPK Pathways (9 papers), PI3K/AKT/mTOR signaling in cancer (7 papers), Cancer-related Molecular Pathways (7 papers), Synthesis and biological activity (6 papers), Lung Cancer Treatments and Mutations (6 papers), Cytokine Signaling Pathways and Interactions (6 papers) and Microtubule and mitosis dynamics (5 papers). The work is most often cited by research in Pharmacology (206 citations), Biochemistry (131 citations), Toxicology (72 citations), Molecular Medicine (91 citations) and Cancer Research (270 citations). Hanyong Chen has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Zigang Dong, Ann M. Bode, Kangdong Liu, Ki Won Lee, Do Young Lim, Mee‐Hyun Lee, Ke Yao, Sungyoung Lee, Sung Keun Jung and Dong Joon Kim. Their work appears in journals such as Cancer Research, Cancer Prevention Research, Molecular Carcinogenesis, Oncotarget and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact